critical limb ischemia

News

Turning to the Use of GP IIb/IIIa Inhibitors, an Emerging Pharmacologic Approach for CLI: An Interview With Craig Walker, MD

10/31/2016

Jennifer Ford ;

The FDA recently approved a new, more concentrated format of the high-dose bolus of the GP IIb/IIIa agent tirofiban (premixed, ready to use, at 250 mcg/mL in a 15 mL vial). Craig Walker, MD, answers questions about the use of GP IIb/IIIa...

The FDA recently approved a new,...

10/31/2016

Vascular Disease Management

News

Turning to the Use of GP IIb/IIIa Inhibitors, an Emerging Pharmacologic Approach for CLI: An Interview With Craig Walker, MD

10/31/2016

The FDA recently approved a new,...

10/31/2016

Vascular Disease Management

Clinical Review

Explaining the Discrepancy Between Lower Patency and Higher Limb Salvage Rates After Revascularization for Critical Limb Ischemia

10/31/2016

Carly N. Richards , MD;

Peter A. Schneider , MD, FACS;

Limb salvage rates that are consistently superior to patency rates for CLI patients have prompted some to question whether perfusion really matters. The authors explore the discrepancy and find that the difference can be explained by several...

Limb salvage rates that are...

10/31/2016

Vascular Disease Management

Editor's Corner

Patency and Limb Salvage Rates in Critical Limb Ischemia

10/30/2016

The discrepancy between patency and limb salvage for patients with the most severe peripheral arterial disease has been the source of much debate. It is possible, however, that the discrepancy is not as wide as previously thought.

The discrepancy between patency...

10/30/2016

Vascular Disease Management

CLI Perspectives

CLI and Low-Profile Devices: Have We Reached a Device Paradigm Shift?

07/09/2016

Jihad A. Mustapha , MD, FACC, FSCAI;

This month, Dr. Mustapha interviews Osamu Iida, MD, Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan.

This month, Dr. Mustapha...

07/09/2016

Cath Lab Digest

Original Research

Sequential Pneumatic Compression Biomechanical Home Therapy Device in the Management of Critical Lower Limb Ischemia for No-Option Patients

07/05/2016

The authors conducted a study to determine the efficacy of sequential pneumatic compression therapy in patients with CLI between 2005 and 2015, where patients were commenced on a 12-week treatment protocol. Sustained clinical improvement was...

The authors conducted a study to...

07/05/2016

Vascular Disease Management

Original Research

Sequential Pneumatic Compression Biomechanical Home Therapy Device in the Management of Critical Lower Limb Ischemia for No-Option Patients

07/05/2016

Mohamed El Sharkawy , MD, PhD, MBBCh;

Sherif Sultan , MCh, MD, FRCS, PhD;

Niamh Hynes , MRCS, MMSc, MD;

Wael Tawfick , MBBCh, MSc, MRCS;

Mohamed Zaki , MCh, MRCS, MD;

Mohamed Elsherif , MCh, MRCS;

Edel P. Kavanagh , BSc, PhD;

The authors conducted a study to...

07/05/2016

Vascular Disease Management

Compression Therapy Could Decrease Pain for 'No-Option' CLI Patients

07/04/2016

Any therapy that can reduce pain for patients for whom revascularization is not possible is worth the attention of interventionalists. Compression therapy has the potential to improve mortality, increase amputation-free survival, and reduce...

Any therapy that can reduce pain...

07/04/2016

Vascular Disease Management

Editor's Corner

Compression Therapy Could Decrease Pain for "No-Option‚" CLI Patients

07/04/2016

Any therapy that can reduce pain...

07/04/2016

Vascular Disease Management

Case Report

Novel Therapeutic Options in Critical Limb Ischemia and Infrapopliteal Disease Using Hybrid Atherectomy and Caged-Balloon Angioplasty

05/22/2016

The authors present a case of critical limb ischemia with nonhealing ulceration that was successfully treated with hybrid atherectomy and constrained-balloon angioplasty with excellent angiographic result and short-term follow-up.

The authors present a case of...

05/22/2016

Vascular Disease Management